Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Deloitte
Cantor Fitzgerald
Daiichi Sankyo
UBS
Express Scripts
AstraZeneca
Citi
US Department of Justice

Generated: April 24, 2018

DrugPatentWatch Database Preview

VERSED Drug Profile

« Back to Dashboard

Which patents cover Versed, and what generic alternatives are available?

Versed is a drug marketed by HLR and Roche and is included in two NDAs.

The generic ingredient in VERSED is midazolam hydrochloride. There are nine drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the midazolam hydrochloride profile page.
Drug patent expirations by year for VERSED
Synonyms for VERSED
08J
12-chloro-9-(2-fluorophenyl)-3-methyl-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene
12-chloro-9-(2-fluorophenyl)-3-methyl-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,8,10,12-hexaene
12-chloro-9-(2-fluorophenyl)-3-methyl-2,4,8-triazatricyclo[8.4.0.0;{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene
12-CHLORO-9-(2-FLUOROPHENYL)-3-METHYL-2,4,8-TRIAZATRICYCLO[8.4.0.0(2),?]TETRADECA-1(10),3,5,8,11,13-HEXAENE
12-CHLORO-9-(2-FLUOROPHENYL)-3-METHYL-2,4,8-TRIAZATRICYCLO[8.4.0.0(2),?]TETRADECA-1(14),3,5,8,10,12-HEXAENE
467M640
4H-Imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-
59467-70-8
8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f]imidazo[1,5-a][1,4]diazepine
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine
8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine
AC1L1HMA
ACN-036275
AK116462
AKOS015842580
AN-39557
API0003385
BDBM21363
BIDD:GT0647
BRN 0625572
Buccolam
Buccolam (TN)
C07524
C18H13ClFN3
CHEBI:6931
CHEMBL655
CS-2907
D00550
D0U6LM
Dazolam
DB00683
DDLIGBOFAVUZHB-UHFFFAOYSA-N
DEA No. 2884
Dormicum
Dormicum (TN)
Dormonid (Salt/Mix)
DTXSID5023320
EINECS 261-774-5
Flormidal (Salt/Mix)
FT-0672402
GTPL3342
HSDB 6751
HY-B0676
Hypnovel
Hypnovel (Salt/Mix)
Hypnovel (TN)
LS-77780
mezolam
Midacum (TN)
Midanium
midazolam
Midazolam (JAN/INN)
Midazolam (JAN/USP/INN)
Midazolam [INN:BAN:JAN]
Midazolam [USP:INN:BAN:JAN]
Midazolam 0.1 mg/ml in Methanol
Midazolam 1.0 mg/ml in Methanol
Midazolam Base
Midazolam hydrochloride, solid
Midazolam hydrochloride, United States Pharmacopeia (USP) Reference Standard
Midazolamum
Midazolamum [INN-Latin]
Midosed
NCGC00168254-01
PL006167
PL006168
PL060780
R60L0SM5BC
Ro 21-3981
SCHEMBL35061
TL8003787
UNII-R60L0SM5BC
USL261
Versed (Salt/Mix)
Versed (TN)
ZINC95626706

US Patents and Regulatory Information for VERSED

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hlr VERSED midazolam hydrochloride INJECTABLE;INJECTION 018654-002 May 26, 1987 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hlr VERSED midazolam hydrochloride INJECTABLE;INJECTION 018654-001 Dec 20, 1985 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche VERSED midazolam hydrochloride SYRUP;ORAL 020942-001 Oct 15, 1998 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for VERSED

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche VERSED midazolam hydrochloride SYRUP;ORAL 020942-001 Oct 15, 1998 ➤ Sign Up ➤ Sign Up
Hlr VERSED midazolam hydrochloride INJECTABLE;INJECTION 018654-002 May 26, 1987 ➤ Sign Up ➤ Sign Up
Hlr VERSED midazolam hydrochloride INJECTABLE;INJECTION 018654-001 Dec 20, 1985 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Mallinckrodt
Federal Trade Commission
Moodys
Chubb
Queensland Health
Accenture
Teva
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.